ContractClinical Trial and Option Agreement • November 10th, 2014 • Asterias Biotherapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledNovember 10th, 2014 Company IndustryConfidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 24b-2 of the Exchange Act of 1934, as amended. Confidential Portions are marked: [***].
ContractClinical Trial and Option Agreement • November 7th, 2014 • Biotime Inc • Biological products, (no disgnostic substances)
Contract Type FiledNovember 7th, 2014 Company IndustryConfidential Materials Omitted and Filed Separately with the Securities and Exchange Commission Pursuant to a Request for Confidential Treatment under Rule 24b-2 of the Exchange Act of 1934, as amended. Confidential Portions are marked: [***].